NCT01003964 2022-04-12
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
National Cancer Center, Korea
Phase 2 Completed
Clinical Trials
9 trialsNCT01156545 2022-04-06
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC
National Cancer Center, Korea
Phase 2 Completed
NCT01537991 2019-01-14
I-START
Velindre NHS Trust
Phase NA Completed
NCT00864331 2013-08-07
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
International Atomic Energy Agency
Phase 3 Completed
NCT01836575 2013-04-22
PS2
Instituto Nacional de Cancer, Brazil
Phase 3 Completed
NCT01385111 2012-10-18
Combined Application of EBUS and EUS in Lung Cancer
National Cancer Center, Korea
Phase NA Completed
NCT01442909 2011-09-29
Pemetrexed Followed by Docetaxel or in Reverse Sequence
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT00686322 2011-09-15
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT01048645 2010-01-13
Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer
National Institute of Cancerología
Phase 2 Completed